one in four high school seniors smoke, and 13 percent of high school males use smokeless tobacco products (CDC, 2012b,g; HHS, 2012).
In recognition that progress in combating cancer will not be fully achieved without addressing the tobacco problem, the National Cancer Policy Forum of the Institute of Medicine (IOM) convened a public workshop, Reducing Tobacco-Related Cancer Incidence and Mortality, June 11–12, 2012, in Washington, DC.2 In opening remarks to the workshop participants, planning committee chair Roy Herbst, professor of medicine and of pharmacology and chief of medical oncology at Yale Cancer Center and Smilow Cancer Hospital, described the goals of the workshop, which were to examine the current obstacles to tobacco control and to discuss potential policy, outreach, and treatment strategies that could overcome these obstacles and reduce tobacco-related cancer incidence and mortality. Experts explored a number of topics, including
• the changing demographics of tobacco users and the changing patterns of tobacco product use;
• the influence of tobacco use on cancer incidence and cancer treatment outcomes;
• tobacco dependence and cessation programs;
• federal- and state-level laws and regulations to curtail tobacco use;
• tobacco control education, messaging, and advocacy;
• financial and legal challenges to tobacco control efforts; and
• research and infrastructure needs to support tobacco control strategies, reduce tobacco-related cancer incidence, and improve cancer patient outcomes.
During the workshop, individual workshop participants raised a number of potential action items to reduce tobacco use and the associated health consequences, including the higher rates of cancer incidence and mortality, as well as suggestions to improve tobacco control policy, research, and advocacy. These suggestions focused on a number of key audiences, includ-
2 This workshop was organized by an independent planning committee whose role was limited to the identification of topics and speakers. This workshop summary was prepared by the rapporteurs as a factual summary of the presentations and discussions that took place at the workshop. Statements, recommendations, and opinions expressed are those of individual presenters and participants, are not necessarily endorsed or verified by the Institute of Medicine or the National Cancer Policy Forum, and should not be construed as reflecting any group consensus.